Clinical trial
Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)
NCT00111384 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00111384 |
|---|---|
| Title | Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1) |
| Official title | Variation in Gene Expression in Neurofibromatosis Type 1 |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Neurofibromatosis Type 1, Legius Syndrome |
| Enrollment | 313 |
| Start date | Jul 27, 2005 |
| First posted | May 20, 2005 |
| Last update posted | Feb 5, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: